WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹907 Cr | ₹760 Cr | ₹626 Cr | ₹527 Cr | ₹489 Cr |
What is the latest Total Liabilities ratio of WINDLAS BIOTECH ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹907 Cr |
| Mar2025 | ₹760 Cr |
| Mar2024 | ₹626 Cr |
| Mar2023 | ₹527 Cr |
| Mar2022 | ₹489 Cr |
How is Total Liabilities of WINDLAS BIOTECH Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹907 Cr | 19.30 | |
| Mar2025 | ₹760 Cr | 21.50 | |
| Mar2024 | ₹626 Cr | 18.73 | |
| Mar2023 | ₹527 Cr | 7.77 | |
| Mar2022 | ₹489 Cr | - | |
Compare Total Liabilities of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,833.8 Cr | 0.1% | -19.8% | -6.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,803.0 Cr | 0.9% | -5% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,833.0 Cr | 3.6% | -1.4% | 37.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,461.0 Cr | 1.7% | -6.7% | 28% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,463.0 Cr | 5.4% | 8.7% | 1.6% | Stock Analytics | |
| CIPLA | ₹109,870.0 Cr | 2.8% | -3.9% | -17.5% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | 0.1% |
-19.8% |
-6.2% |
| SENSEX | -0.3% |
-1.6% |
-12.3% |
You may also like the below Video Courses